SCHEMBL9360788

SCHEMBL9360788

O=Cc1ccnc2cc(C(F)(F)F)ccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.49
CCR1 P32246 1/20 0.49
CCR5 P51681 1/20 0.49
CCR8 P51685 1/20 0.49
ADRB2 P07550 1/20 0.48
NCF1 P14598 1/20 0.48
GSK3B P49841 5/20 0.44
CLK4 Q9HAZ1 5/20 0.44
GSK3A P49840 4/20 0.44
KDR P35968 4/20 0.44
PRKD3 O94806 3/20 0.44
MAP4K4 O95819 3/20 0.44
AURKB Q96GD4 3/20 0.44
DYRK3 O43781 3/20 0.44
DYRK1A Q13627 3/20 0.44
STK17A Q9UEE5 3/20 0.44
CLK2 P49760 3/20 0.44
CDK5 Q00535 3/20 0.44
PRKD2 Q9BZL6 2/20 0.44
CDK2 P24941 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5407537 0.89 SLC22A12 (0.46) PARP1CCR1CCR5CCR8ADRB2
SCHEMBL2201230 0.80 ADRB2 (0.52) PARP1ADRB2NCF1GSK3BCLK4
SCHEMBL31121093 0.80 ADRB2 (0.52) PARP1ADRB2NCF1GSK3BCLK4
SCHEMBL29267442 0.77 PARP1 (0.46) PARP1ADRB2NCF1GSK3BCLK4
SCHEMBL22854 0.76 ADRB2 (0.52) PARP1CCR1CCR5CCR8ADRB2
SCHEMBL30174440 0.76 ADRB2 (0.52) PARP1CCR1CCR5CCR8ADRB2
SCHEMBL18582354 0.76 ADRB2 (0.52) PARP1ADRB2NCF1GSK3BCLK4
SCHEMBL8367913 0.75 PARP1 (0.50) PARP1ADRB2NCF1GSK3BCLK4
SCHEMBL9829215 0.75 ADRB2 (0.51) PARP1ADRB2NCF1GSK3BCLK4
SCHEMBL2345433 0.75 ADRB2 (0.51) PARP1ADRB2NCF1GSK3BCLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0365863-B1 Novel quinolyloxazole-2-ones useful as proteinkinase C inhibitors MERRELL DOW PHARMA (US) 1994-08-17 EP disclosed
EP-0428105-B1 Use of quinolyl- and isoquinolyloxazole-2-ones for the production of a medicament for the prevention of glycoprotein enveloped virus infectivity MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
EP-0428107-B1 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors MERRELL DOW PHARMA (US) 1994-01-19 EP disclosed
US-5190957-A TREATMENT OF MULTI-DRUG RESISTANT TUMORS WITH QUINOLYL-AND ISOQUINOLYLOXAZOLE-2-ONES MERRELL DOW PHARMACEUTICALS INC. (US) 1993-03-02 US disclosed
US-5061715-A Useful in treating AIDS and ARC MERRELL DOW PHARMACEUTICALS INC. (US) 1991-10-29 US disclosed
EP-0428107-A2 Use of quinolyl-and isoquinolyloxanole-2-ones for the production of a medicament for the treatment of multi-drug resistant tumors MERRELL DOW PHARMACEUTICALS INC. (US) 1991-05-22 EP disclosed
EP-0428105-A2 Use of quinolyl- and isoquinolyloxazole-2-ones for the production of a medicament for the prevention of glycoprotein enveloped virus infectivity MERRELL DOW PHARMACEUTICALS INC. (US) 1991-05-22 EP disclosed
US-4999431-A Reacting A Bromoquinoline Compound With Butyllithium And An N-Methyl-N-Methoxyalkanamide; Intermediates for Quinolyloxazole-2-ones MERRELL DOW PHARMACEUTICALS (US) 1991-03-12 US disclosed
EP-0096214-B1 ANTIBACTERIAL PYRIMIDINE COMPOUNDS THE WELLCOME FOUNDATION LIMITED (GB) 1991-02-27 EP disclosed
US-4990519-A Antiasthma, hypotensive agents, bronchodilator agents MERRELL DOW PHARMACEUTICALS (US) 1991-02-05 US disclosed
EP-0365863-A2 Novel quinolyloxazole-2-ones useful as proteinkinase C inhibitors MERRELL DOW PHARMACEUTICALS INC. (US) 1990-05-02 EP disclosed
US-4886811-A HYPOTENSIVE AGENTS AND VASODILATORS MERRELL DOW PHARMACEUTICALS (US) 1989-12-12 US disclosed
EP-0096214-A1 Antibacterial pyrimidine compounds THE WELLCOME FOUNDATION LIMITED (GB) 1983-12-21 EP disclosed